Viemed Healthcare: Moore Faster may sell 246K shares

Sales under the plan are capped at 246,000 shares and may begin no earlier than December 24, 2026.

Rhea-AI Filing Summary

Viemed Healthcare, Inc. disclosed that Moore Faster LLC entered into a Rule 10b5-1 trading plan on September 24, 2026, under which Morgan Stanley Smith Barney LLC may sell up to 246,000 common shares held by the LLC. The selling period is to begin on a date determined under the plan, no earlier than December 24, 2026, and end November 30, 2027, subject to predetermined trading conditions.

Michael Moore, identified as an employee and officer of Viemed, is reported as beneficial owner of 2,294,018 common shares, or 5.9% of the class. This includes 189,090 shares held directly, 1,585,812 held by Moore Faster LLC, and 519,116 shares issuable upon options vested or exercisable within 60 days. Viemed reported 38,088,228 common shares outstanding as of July 27, 2026.

Key Figures

Shares covered by trading plan: Up to 246,000 common shares Michael Moore beneficial ownership: 2,294,018 common shares; 5.9% Moore Faster LLC beneficial ownership: 1,585,812 common shares; 4.2% +2 more

5 metrics

Shares covered by trading plan Up to 246,000 common shares Moore Faster LLC plan dated September 24, 2026

Michael Moore beneficial ownership 2,294,018 common shares; 5.9% Includes shares held directly, shares held by Moore Faster LLC, and shares issuable upon options

Moore Faster LLC beneficial ownership 1,585,812 common shares; 4.2% Reported beneficial ownership

Common shares outstanding 38,088,228 common shares As of July 27, 2026

Shares issuable upon options 519,116 shares Options vested or exercisable within 60 days, included in Moore's beneficial ownership calculation

Key Terms

Rule 10b5-1(c), beneficial ownership, restricted share units

3 terms

Rule 10b5-1(c) regulatory

"intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

beneficial ownership financial

"The percent of class provided for the Reporting Persons"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

restricted share units financial

"an award of 99,243 restricted share units granted to Moore vested"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VMD shares can Moore Faster LLC sell under its trading plan?

The plan permits Morgan Stanley Smith Barney LLC to sell up to 246,000 common shares held by Moore Faster LLC. The selling period is to begin no earlier than December 24, 2026, and end November 30, 2027, subject to predetermined trading conditions.

How many VMD shares does Michael Moore beneficially own?

Michael Moore is reported as beneficial owner of 2,294,018 common shares, or 5.9% of the class. The amount includes 189,090 shares held directly, 1,585,812 held by Moore Faster LLC, and 519,116 shares issuable upon options vested or exercisable within 60 days. Viemed reported 38,088,228 common shares outstanding as of July 27, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 05:23 PM Accepted by SEC EDGAR 09/24/2026 - 05:22 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)

Viemed Healthcare, Inc.

(Name of Issuer)

Common Shares, No Par Value

(Title of Class of Securities)

92663R105

(CUSIP Number)

Michael Moore
625 E. Kaliste Saloom Rd.,
Lafayette, LA, 70508
337-504-3802

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

09/24/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 92663R105

1

Name of reporting person

Michael Moore

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 708,206.00
8	Shared Voting Power 1,585,812.00
9	Sole Dispositive Power 708,206.00
10	Shared Dispositive Power 1,585,812.00

11

Aggregate amount beneficially owned by each reporting person

2,294,018.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

5.9 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

CUSIP Number(s): 92663R105

1

Name of reporting person

Moore Faster LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

LOUISIANA

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 1,585,812.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 1,585,812.00

11

Aggregate amount beneficially owned by each reporting person

1,585,812.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.2 %

14

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Shares, No Par Value
(b)	Name of Issuer: Viemed Healthcare, Inc.
(c)	Address of Issuer's Principal Executive Offices: 625 E. Kaliste Saloom Rd., Lafayette, LOUISIANA , 70508.
Item 1 Comment: This Amendment No. 3 ("Amendment No. 3") amends and supplements the Schedule 13D initially filed on February 12, 2021, as amended on May 18, 2023 and February 15, 2024 (as so amended, the "Schedule 13D"), and is filed to report changes in the beneficial ownership of Common Shares by Michael Moore ("Moore") and Moore Faster LLC, a Louisiana limited liability company ("MF LLC"), and to report the adoption of a trading plan by MF LLC intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Except as specifically amended and supplemented by this Amendment No. 3, the Schedule 13D remains unchanged. All capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.
Item 4.	Purpose of Transaction
	Item 4 of the Schedule 13D is hereby amended and restated in its entirety as follows: Each of the Reporting Persons holds the Common Shares as reported herein for investment purposes and does not have any specific plans or proposals regarding the Issuer in such Reporting Person's capacity as a holder of Common Shares. Except as set forth below, each of the Reporting Persons does not have any current plans or proposals which relate to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D. On September 24, 2026, MF LLC entered into a trading plan with Morgan Stanley Smith Barney LLC (the "Trading Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Pursuant to the Trading Plan, Morgan Stanley Smith Barney LLC may sell up to 246,000 Common Shares of the Issuer held by MF LLC during the period beginning on the Selling Start Date, as determined under the Trading Plan, which will be no earlier than December 24, 2026, and ending November 30, 2027, subject to predetermined trading conditions established under the Trading Plan. The Trading Plan was adopted at a time when neither Moore nor MF LLC was aware of any material non-public information regarding the Issuer. A copy of the Trading Plan is filed as Exhibit 99.2 to this Amendment No. 3 and is incorporated herein by reference.
Item 5.	Interest in Securities of the Issuer
(a)	The percent of class provided for the Reporting Persons is calculated in accordance with Rule 13d-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is based on 38,088,228 Common Shares outstanding as of July 27, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 3, 2026. For purposes of calculating Moore's beneficial ownership percentage, 519,116 Common Shares issuable upon the exercise of options that are vested or exercisable within 60 days are deemed outstanding in accordance with Rule 13d-3(d)(1)(i). Moore is the beneficial owner of 2,294,018 Common Shares, representing 5.9% of the class, consisting of 189,090 Common Shares held directly by Moore, 1,585,812 Common Shares held by MF LLC and 519,116 Common Shares issuable upon the exercise of options that are vested or exercisable within 60 days. MF LLC is the beneficial owner of 1,585,812 Common Shares, representing 4.2% of the class.
(b)	Moore has the sole power to vote or to direct the vote of and the sole power to dispose of or to direct the disposition of 708,206 Common Shares. Moore has shared power to vote or to direct the vote of and shared power to dispose of or to direct the disposition of 1,585,812 Common Shares. MF LLC has no sole voting or dispositive power and has shared voting and dispositive power with respect to 1,585,812 Common Shares. Moore owns 50% of the ownership units in MF LLC and serves as a general manager of MF LLC. The information provided on the cover pages with respect to the beneficial ownership of Moore and MF LLC is incorporated herein by reference.
(c)	On January 4, 2021, an award of 99,243 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 30,917 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 99,243 restricted share units. On January 4, 2021, an award of 43,513 stock options awards granted to Moore vested. On January 17, 2021, an award of 121,299 stock options awards granted to Moore vested. On January 21, 2021, Moore received a grant of 120,584 options to acquire Common Shares under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 17, 2022, an award of 121,299 stock options awards granted to Moore vested. On January 18, 2022, Moore received a grant of 85,410 options to acquire Common Shares and 56,937 restricted stock units under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 21, 2022, an award of 40,195 stock options awards granted to Moore vested. On January 17, 2023, Moore received a grant of 80,818 restricted stock units under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 17, 2023, an award of 52,224 stock options awards granted to Moore vested. On January 18, 2023, an award of 28,470 stock options awards granted to Moore vested and an award of 18,979 restricted share units granted to Moore vested which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 6,767 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 18,979 restricted share units. On January 21, 2023, an award of 40,195 stock options awards granted to Moore vested. On August 14, 2023, Moore transferred 1,722,614 Common Shares to MF LLC for estate planning purposes. On January 17, 2024, an award of 26,939 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 9,223 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 26,939 restricted share units. On January 18, 2024, an award of 28,470 stock options awards granted to Moore vested and an award of 18,979 restricted share units granted to Moore vested which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 5,761 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 18,979 restricted share units. On January 21, 2024, an award of 40,195 stock options awards granted to Moore vested. On January 29, 2024, Moore received a grant of 80,527 restricted stock units under the 2020 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 17, 2025, an award of 26,939 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 8,762 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 26,939 restricted share units. On January 18, 2025, an award of 28,470 stock options granted to Moore vested and an award of 18,979 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 5,761 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 18,979 restricted share units. On January 21, 2025, Moore received a grant of 102,642 restricted stock units under the Viemed Healthcare, Inc. 2024 Long Term Incentive Plan, as amended (the "2024 Incentive Plan"), which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 29, 2025, an award of 26,843 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 8,147 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 26,843 restricted share units. On June 27, 2025, Moore exercised 3,486 stock options and sold the 3,486 Common Shares acquired upon exercise. On June 30, 2025, Moore exercised 127,053 stock options and sold the 127,053 Common Shares acquired upon exercise. On June 30, 2025, Moore exercised 50,777 stock options and sold the 50,777 Common Shares acquired upon exercise. On August 12, 2025, Moore sold 50,090 Common Shares. On January 17, 2026, an award of 26,939 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 8,548 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 26,939 restricted share units. On January 19, 2026, Moore received a grant of 118,759 restricted stock units under the 2024 Incentive Plan, which award vests in three equal annual installments beginning on the first anniversary of the grant date. On January 21, 2026, an award of 34,214 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 9,358 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 34,214 restricted share units. On January 29, 2026, an award of 26,842 restricted share units granted to Moore vested, which entitled Moore with the right to receive one Common Share per restricted stock unit. The Issuer withheld 7,342 Common Shares to satisfy Moore's tax obligation resulting from the vesting of the 26,842 restricted share units. On March 18, 2026, MF LLC sold 31,570 Common Shares. On March 19, 2026, MF LLC sold 40,232 Common Shares. On March 20, 2026, MF LLC sold 65,000 Common Shares.
(d)	Not applicable.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Item 6 of the Schedule 13D is hereby amended and restated in its entirety as follows: Moore, as an employee and officer of the Issuer, is eligible to participate in each of the Incentive Plans and in the 2024 Incentive Plan. The information regarding the Trading Plan set forth in Item 4 of this Amendment No. 3 is incorporated herein by reference. A copy of the Trading Plan is filed as Exhibit 99.2 to this Amendment No. 3 and is incorporated herein by reference.
Item 7.	Material to be Filed as Exhibits.
	6. Viemed Healthcare, Inc. 2024 Long Term Incentive Plan. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 6, 2024. 7. Amendment to the 2024 Long Term Incentive Plan, effective June 5, 2025. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 5, 2025. 8. Second Amendment to the 2024 Long Term Incentive Plan, effective June 4, 2026. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 4, 2026. 99.2. Rule 10b5-1 Trading Plan, dated September 24, 2026, between Moore Faster LLC and Morgan Stanley Smith Barney LLC. Certain schedules to Exhibit 99.2 have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished to the Securities and Exchange Commission or its staff upon request.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Michael Moore

Signature:	/s/ Michael Moore
Name/Title:	Michael Moore
Date:	09/24/2026

Moore Faster LLC

Signature:	/s/ Michael Moore
Name/Title:	Michael Moore/General Manager
Date:	09/24/2026